Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Development of Agenda for Pharmaceutical Care Service Research and Development using the Analytical Hierarchy Process

약료서비스 R&D 고도화를 위한 우선순위 기반 전략과제 설정

  • Received : 2019.03.09
  • Accepted : 2019.03.18
  • Published : 2019.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Although the importance of pharmaceutical care service has been growing to meet the needs of customers with the improvement of clinical and humanistic outcomes, there was not a systematic strategy to promote research in Korea. The aim of this study was to suggest the core agendas for pharmaceutical care services research and development (R&D) considering priorities. Methods: Based on desk researches, we developed R&D agendas for the needs of improving pharmaceutical care services in the area of institution, community, and public health. To determine the priority of agendas in developing pharmaceutical care service, analytic hierarchy process (AHP) analysis was performed by the 14 experts. Criteria and subcriteria were assessed for significance by pairwise comparisons. Then, agendas were evaluated for importance according to each subcriteria, and rank ordered considering the weight calculated by multiplying the importance scores of the criteria and the subcriteria. Results: We derived 25 agendas including 13 for institutional pharmaceutical care service, 8 for community pharmaceutical care service, and 4 for public-health related pharmaceutical care service. AHP model was constructed based on 4 criteria and 8 subcriteria by a hierarchical structure. From the AHP survey, the 'Development of pharmaceutical care service for metabolic and chronic disease' agenda accounted for the highest priority. Conclusion: We have developed the R&D agendas of the pharmaceutical care service which should be promoted. The results should be utilized by the government to nationally support the development of the standards and relevant regulations related to pharmaceutical care services in Korea.

Keywords

References

  1. Chapter 1. Article 3 (Definition). In: Framework Act on Health and Medical Services. Revised March 17, 2010.
  2. National Health Insurance Corporation. Medical care assistance statistical at 2016. Available from http://kosis.kr/statHtml/statHtml.do?orgId=350&tblId=DT_920015N_222&conn_path=I2. Accessed Jan 7, 2019.
  3. The World Health Organization (WHO). The role of the pharmacist in the health care system. Available from http://apps.who.int/medicinedocs/en/d/Jh2995e/1.6.2.html. Accessed Jan 7, 2019.
  4. McMullin ST, Hennenfent JA, Ritchie DJ, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 1999;159(19):2306-9. https://doi.org/10.1001/archinte.159.19.2306
  5. Boyko WL Jr, Yurkowski PJ, Ivey MF, et al. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 1997;54(14):1591-5. https://doi.org/10.1093/ajhp/54.14.1591
  6. Hepler CD and Strand LM. Opportunity and responsibility in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
  7. Yoon JH. Development of a pharmaceutical care service model for patients with diabetes in ambulatory care settings. Korean J Clin Pharm 2017;27(1):1-8. https://doi.org/10.24304/kjcp.2017.27.1.1
  8. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc 2008;48(2):203-11. https://doi.org/10.1331/JAPhA.2008.07108
  9. Moore JM, Shartle D, Faudskar L, et al. Impact of a patient-centered pharmacy program and intervention in a high-risk group. J Manag Care Pharm 2013;19(3):228-36.
  10. Reinke T. Medication therapy management program in N.C. saves $13 million. Managed care 2011;20(10):17-8.
  11. Simpson SH, Majumdar SR, Tsuyuki RT, et al. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2011;34(1):20-6. https://doi.org/10.2337/dc10-1294
  12. Polgreen LA, Han J, Carter BL, et al. Cost-effectiveness of a physician-pharmacist collaboration intervention to improve blood pressure control. Hypertension 2015;66(6):1145-51. https://doi.org/10.1161/HYPERTENSIONAHA.115.06023
  13. Almomani BA, Mayyas RK, Ekteish FA, et al. The effectiveness of clinical pharmacist’s intervention in improving asthma care in children and adolescents: Randomized controlled study in Jordan. Patient Educ Couns 2017;100(4):728-35. https://doi.org/10.1016/j.pec.2016.11.002
  14. Weddle SC, Rowe AS, Jeter JW, et al. Assessment of clinical pharmacy interventions to reduce outpatient use of high-risk medications in the elderly. J Manag Care Spec Pharm 2017;23(5):520-4.
  15. Martin P, Tamblyn R, Benedetti A, et al. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: The D-PRESCRIBE randomized clinical trial. JAMA 2018;320(18):1889-98. https://doi.org/10.1001/jama.2018.16131
  16. Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm 2013;19(5):408-16. https://doi.org/10.18553/jmcp.2013.19.5.408
  17. Kang M and Bang JS. Pharmacists' perception for the current and future pharmaceutical services. Korean J Clin Pharm 2017;27(4):228-37. https://doi.org/10.24304/kjcp.2017.27.4.228
  18. Sohn HS, Kim H, Park H, et al. Pharmaceutical care services of community pharmacies in Korea through the review of literature. Korean J Clin Pharm 2015;25(1):18-26.
  19. Lee YT. Development concept and research theme of healthcare/public service. Seoul: Korea Health Industry Development Institute, 2011;2011-49.
  20. The Korea Health Industry Development Institute (KHIDI). Research and development statistics in Healthcare. Available from https://www.khidi.or.kr/fileDownload?titleId=340632&fileId=1&fileDownType=C¶mMenuId=MENU02114. Accessed Dec 7, 2018.
  21. Kim JS and Park YS. Priority analysis of the healthcare policy using analytic hierarchy proce. J Korean Med Assoc 2017;60(2):164-72. https://doi.org/10.5124/jkma.2017.60.2.164
  22. Oh EG, Jang YS, Gong SL. Development of agenda priority for nursing service research and development. J Korean Acad Nurs Adm 2015;21(1):99-110. https://doi.org/10.11111/jkana.2015.21.1.99
  23. Liberatore MJ and Nydick RL. The analytic hierarchy process in medical and health care decision making: A literature review. Eur J Oper Res 2008 1:194-207. https://doi.org/10.1016/j.ejor.2007.05.001
  24. American Society of Health-System Pharmacists. ASHP guidelines: minimum standard for pharmacies in hospitals. Am J Health-Syst Pharm 2013;70(18):1619-30. https://doi.org/10.2146/sp130001
  25. Pharmacy practice in hospitals and other collaborative healthcare settings: Position statements. Ottawa: Canadian Society of Hospital Pharmacists 2016;5-14.
  26. The Society of Hospital Pharmacists of Australia. Standards of Practice for Clinical Pharmacy Services. Available from https://www.shpa.org.au/resources/standards-of-practice-for-clinical-pharmacy-services. Accessed Oct 28, 2018.
  27. Lee JI, Kim MS, Jo GT, et al. Information processing and interdisciplinary technology: Priority setting for future core technologies in biosystems engineering using the analytic hierarchy process. J Biosyst Eng 2004;29(2):187-94. https://doi.org/10.5307/JBE.2004.29.2.187
  28. Aczél J and Saaty TL. Procedures for synthesizing ratio judgements. J Math Psychol 1983;27:93-102. https://doi.org/10.1016/0022-2496(83)90028-7
  29. Batalden PB and Davidoff F. What is "quality improvement" and how can it transform healthcare? Qual Saf Health Care 2007;16(1):2-3. https://doi.org/10.1136/qshc.2006.022046
  30. Statistics Korea. Causes of death statistics in 2017. Available from http://kostat.go.kr/portal/eng/pressReleases/8/10/index.board?bmode=download&bSeq=&aSeq=371140&ord=1. Accessed Nov 8, 2018.
  31. Choi YH and Sohn UD. The surveillance of adverse drug reaction (ADR) reported. Korean J Clin Pharm 2003;13(2):72-81.
  32. Budnitz DS, Pollock DA, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296(15):1858-66. https://doi.org/10.1001/jama.296.15.1858
  33. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282(3):267-70. https://doi.org/10.1001/jama.282.3.267
  34. 2016 National healthcare survey. Available from http://www.mohw.go.kr/react/modules/download.jsp?BOARD_ID=320&CONT_SEQ=344184&FILE_SEQ=227558. Accessed Jan 9, 2019.
  35. American Society of Health-System Pharmacists. ASHP statement on pharmacy services to the emergency department. Am J Health-Syst Pharm 2008;65(24):2380-3. https://doi.org/10.2146/ajhp080417
  36. Digiantonio N, Lund J, Bastow S. Impact of a pharmacy-led medication reconciliation program. P T. 2018;43(2):105-10.
  37. Park SJ and Shin HT. The Major Barriers to Provision of Pharmaceutical Care Service in Compliance with Internationally Recognized Good Pharmacy Practice Standards in Community Pharmacies in Korea: A Questionnaire Survey. Kor J Clin Pharm 2014;24(4):272-81.
  38. Yoon DY, Ha JE, Sohn HS. A Survey of the General Publics' Perceptions and Expectations for Community Pharmacy Services. J Korean Academy of Social & Managed Care Pharmacy 2017;6(1):38-45.
  39. Kang RY, Lee YS, Yoo BK. Current status of pharmaceutical care service in community pharmacy in Korea. Yakhak Hoeji 2018;62(1):14-20. https://doi.org/10.17480/psk.2018.62.1.14
  40. Yoon D. What We Need to Prepare for the Fourth Industrial Revolution. Healthc Inform Res 2017;23(2):75-6. https://doi.org/10.4258/hir.2017.23.2.75
  41. International Pharmaceutical Foundation (FIP). Good Pharmacy Practice - Standards for Quality Services. Available from https://www.fip.org/uploads/database_file.php?id=331&table_id=. Accessed Dec 26, 2018.
  42. Barnett MJ, Frank J, Wehring H, et al. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm 2009;15(1):18-31. https://doi.org/10.18553/jmcp.2009.15.1.18
  43. Hui RL, Yamada BD, Spence MM, et al. Impact of a Medicare MTM program: evaluating clinical and economic outcomes. Am J Manag Care 2014;20(2):e43-51.
  44. Matheson C, Thiruvothiyur M, Robertson H, et al. Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development. Int J Drug Policy 2016;27:105-12. https://doi.org/10.1016/j.drugpo.2015.11.006
  45. Chapter I: General Provisions. Article 2 (Definitions). In: Public Health and Medical Services Act. Revised February 3, 2016.
  46. Golchin N, Frank SH, Vince A3, et al. Polypharmacy in the elderly. J Res Pharm Pract 2015;4(2):85-8. https://doi.org/10.4103/2279-042X.155755
  47. Brahma DK, Wahlang JB, Marak MD, et al. Adverse drug reactions in the elderly. J Pharmacol Pharmacother 2013;4(2):91-4. https://doi.org/10.4103/0976-500X.110872
  48. Bell SP, Schnipper JL, Goggins K, et al. Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial. J Gen Intern Med 2016;31(5):470-7. https://doi.org/10.1007/s11606-016-3596-3
  49. National Health Literacy Act of 2007. Available from https://www.congress.gov/bill/110th-congress/senate-bill/2424. Accessed Jan 7, 2019.
  50. Weekes LM, Mackson JM, Fitzgerald M, et al. National Prescribing Service: creating an implementation arm for national medicines policy. Br J Clin Pharmacol 2005;59(1):112-6. https://doi.org/10.1111/j.1365-2125.2005.02231.x
  51. Mukherjee M, Stoddart A, Gupta RP, et al. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. BMC Med 2016;14(1):113. https://doi.org/10.1186/s12916-016-0657-8
  52. Pinnock H, Parke HL, Panagioti M, et al. Systematic meta-review of supported self-management for asthma: a healthcare perspective. BMC Med 2017;15(1):64. https://doi.org/10.1186/s12916-017-0823-7
  53. Kim JS and Park YS. Priority analysis of the healthcare policy using analytic hierarchy process. J Korean Med Assoc 2017;60(2):164-72. https://doi.org/10.5124/jkma.2017.60.2.164
  54. Oh EG, Jang YS, Gong SL, Lee YJ. Development of Agenda Priority for Nursing Service Research and Development. J Korean Acad Nurs Adm 2015;21(1):99-110. https://doi.org/10.11111/jkana.2015.21.1.99
  55. Kim WY, Kim DH, Choi YC. A Study on application Limitation of AHP priority vector with Expert measurement. J Korean Soc Aviat Aeronaut 2010;18(3):92-8.